- Summits
- Sponsorship
- News
- About
The final day of MedTech World North America 2026 brought together investors, founders, clinicians, strategics, and innovators for a packed agenda focused on the realities of scaling healthcare innovation.
The morning began with a Portfolio Showcase and Investor Breakfast powered by Edge Medical Ventures at Canopy by Hilton West Palm Beach, setting the tone for a day centered around capital formation, commercialization strategy, and the future direction of MedTech.
As attendees moved into the Oceana Ballroom, conversations quickly turned toward one of the industry’s defining questions: how startups can align with strategic investors while building sustainable businesses.
The session “Strategic Money, Strategic Risk: What Corporate Venture Really Wants from MedTech” examined how corporate venture investors evaluate opportunities beyond financial return alone. The discussion highlighted how strategic priorities, clinical alignment, and long-term platform value increasingly shape investment decisions in MedTech. Panelists also explored the disconnect that often exists between startup expectations and what corporate investors actually seek from partnerships.
Neurotechnology took center stage in “Scaling Neuro Innovation: Capital, Clinical Adoption & Corporate Pathways,” where speakers discussed the growing importance of clinical validation, cybersecurity, infrastructure readiness, and strategic collaboration in bringing neuro innovations to scale. The session reflected a broader industry trend where trust, interoperability, and system-level adoption are becoming just as important as breakthrough technology itself.
Operational execution became the focus during “What Breaks MedTech Timelines,” a candid discussion on the common challenges that delay commercialization. Regulatory planning, reimbursement preparation, clinical trial management, and market access strategy were identified as recurring pressure points that can significantly affect growth trajectories when not addressed early.
The morning continued with a series of company showcases, where emerging MedTech companies presented technologies spanning imaging, diagnostics, surgical innovation, augmented reality, and digital health solutions. The presentations demonstrated the breadth of innovation currently moving through the healthcare pipeline and gave attendees a closer look at technologies preparing for clinical and commercial expansion.
Longevity and artificial intelligence became key themes during “From Lab to Lifespan: AI, Aging & the Future of Longevity Innovation.” Discussions explored how AI-driven biological modeling, cellular reprogramming, and next-generation therapeutics are increasingly moving from research environments into investment conversations and clinical development pathways. The panel reflected growing confidence that longevity science is transitioning into a meaningful healthcare market category.
Following lunch, the conversation shifted toward mergers, acquisitions, and strategic positioning during “Exit by Design: How the Best MedTech Companies Engineer Their Acquisition.” Panelists discussed how acquisition readiness often begins far earlier than founders anticipate, with product decisions, regulatory pathways, reimbursement strategies, and operational discipline all contributing to long-term enterprise value.
Artificial intelligence remained a major focus during “Beyond the Algorithm — How AI is Being Built, Powered & Deployed in Healthcare.” Rather than discussing AI as a future concept, the session focused on the practical realities of implementation, including clinical trust, infrastructure requirements, enterprise deployment, and validation standards necessary for healthcare adoption.
Throughout the day, attendees also had the opportunity to engage with perspectives from leaders across technology, investment, and healthcare, including David Roman, Managing Director, Co-Head of Healthcare Global Investment Research, Goldman Sachs; Joe Shonkwiler, Healthcare and Life Science Lead, Venture Capital BD at Google, and Jonathan Norris, Managing Director at HSBC Innovation Banking, further reflecting the cross-sector conversations driving the MedTech industry forward.
Regional innovation ecosystems also came into focus during “The Florida Advantage: Capital, Clinical & Commercial Strength.” The discussion explored why Florida is increasingly being recognized as a competitive MedTech hub, supported by strong clinical institutions, investment activity, research infrastructure, and growing commercialization opportunities.
The afternoon fireside “Follow the Money: MedTech Equities, Trends & Capital Market Forces” closed the conference sessions with a broader market perspective. Speakers examined how capital markets, healthcare investment trends, and macroeconomic conditions are reshaping MedTech business models and investor priorities in 2026.
One of the most anticipated moments of the day was the MedTech World Startup Pitch Competition, where startups from across the global MedTech ecosystem presented their technologies before an international judging panel. The competition featured innovations across diagnostics, cardiovascular care, surgical technologies, imaging, and digital health, reflecting the diversity of ideas entering the sector.
The competition concluded with Aliform taking the top spot, earning recognition for its solution focused on tissue tethering technology. This year’s pitch competition was powered by Ascend Clinical Research, Beacon Launch Partners, Blue Goat Cyber, FloodGate Medical, KARV, Malta Enterprise, and Prolucid Technologies.
Beyond the stage programming, Day 2 maintained the energy seen throughout the week, with the exhibition floor and startup village remaining active hubs for networking, investor meetings, and product demonstrations. Attendees continued to connect through scheduled one-to-one meetings, informal discussions, and side events happening across the venue.
Additional networking opportunities extended into the evening through the luncheon titled “A Clinician’s Place in MedTech Innovation,” co-hosted by BlackPoint Capital and ASPS Ventures, followed by the Prolucid Happy Hour powered by Prolucid Technologies.
As MedTech World concluded its North America edition for 2026, the final day reflected many of the themes shaping the current healthcare innovation environment: disciplined capital deployment, practical AI implementation, strategic collaboration, and a growing focus on building companies prepared not only for innovation, but for long-term scalability and adoption.
Attention is already turning toward the next edition of MedTech World North America 2027, with pre-registrations now open for the event taking place from May 5–7, 2027. Alongside discussions on investment, innovation, and commercialization, the 2027 edition will also introduce dedicated startup tracks designed to further support early-stage companies navigating growth, partnerships, and market entry within the global MedTech ecosystem.
